509 related articles for article (PubMed ID: 15112309)
1. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization.
Bian DJ; Xiao EH; Hu DX; Chen XY; Situ WJ; Yuan SW; Sun JL; Yang LP
Chin J Cancer; 2010 Feb; 29(2):198-201. PubMed ID: 20109351
[TBL] [Abstract][Full Text] [Related]
3. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
4. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.
Wu B; Peng WJ; Wang PJ; Gu YJ; Li WT; Zhou LP; Tang F; Zhong GM
Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
6. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.
Chen CY; Li CW; Kuo YT; Jaw TS; Wu DK; Jao JC; Hsu JS; Liu GC
Radiology; 2006 May; 239(2):448-56. PubMed ID: 16569781
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
[TBL] [Abstract][Full Text] [Related]
8. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
10. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
Yu JS; Kim JH; Chung JJ; Kim KW
J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
Fan WJ; Zhang L; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
Xiao YP; Xiao EH; Luo JG; Bian DJ; Li MQ; He Z; Shang QL; Liang B
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):914-6. PubMed ID: 19173992
[TBL] [Abstract][Full Text] [Related]
13. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
16. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
Kim SH; Lee WJ; Lim HK; Lim JH
J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
[TBL] [Abstract][Full Text] [Related]
17. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
18. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.
Aoki T; Imamura H; Hasegawa K; Matsukura A; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Arch Surg; 2004 Jul; 139(7):766-74. PubMed ID: 15249411
[TBL] [Abstract][Full Text] [Related]
19. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
[TBL] [Abstract][Full Text] [Related]
20. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
